The customer
DocMorris is a leading online pharmacy, marketplace and professional healthcare company with strong brands in Germany and other European countries. DocMorris is active in Spain and France and is the leading marketplace for healthcare and personal care products in Southern Europe. The company operates at the intersection of healthcare, technology and e-commerce and strives to create a digital healthcare ecosystem in which people can manage their health at the click of a button. In 2023, around 1,600 employees with over nine million active customers generated an external revenue of CHF 1,038 million.
The challenge
With the introduction of the e-prescription on 1 January 2024, patients were able to redeem an e-prescription using the gematik app, their electronic health card (eGK in German) or via an e-prescription printout in local pharmacies. The health card option was not initially available for online pharmacies, as this was only intended to be a plug-in solution for a card reader. They were therefore unable to participate in the e-prescription process. The innovative redemption method using eHealth-CardLink for online pharmacy apps has now closed this gap.
The CardLink product makes it possible to access digital applications with the electronic health card without physical eHealth card readers. Patients can use their online pharmacy's app to redeem their prescription and have their medication delivered. You need an NFC-enabled (Near Field Communication) smartphone to scan your health card in the app and authenticate yourself.
As one of the leading online pharmacies in Germany, DocMorris had set itself the goal of being one of the first providers to obtain the gematik authorisation for eHealth-CardLink as a new gematik feature of its app. In addition to the tight time constrains, the test requirements and test windows specified by the gematik posed a challenge. The latter had to be adhered to in order to obtain a timely approval. achelos was selected as partner for implementing the mandatory gematik tests (EvT).